A Comparison of PRC-063 and Lisdexamfetamine in the Driving Performance of Adults With ADHD

Clinical trial NCT02555150 · COMPLETED

Trial details

NCT number: NCT02555150
Sponsor: Rhodes Pharmaceuticals, L.P.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2015-09-01
Primary completion: 2017-01-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.